Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 552

1.

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy.

Takada K, Kohashi K, Shimokawa M, Haro A, Osoegawa A, Tagawa T, Seto T, Oda Y, Maehara Y.

Lung Cancer. 2019 Feb;128:26-32. doi: 10.1016/j.lungcan.2018.12.008. Epub 2018 Dec 10.

PMID:
30642449
2.

KEYNOTE-025: Phase 1b Study of Pembrolizumab in Japanese Patients With Previously Treated PD-L1-Positive Advanced NSCLC.

Nishio M, Takahashi T, Yoshioka H, Nakagawa K, Fukuhara T, Yamada K, Ichiki M, Tanaka H, Seto T, Sakai H, Kasahara K, Satouchi M, Han SR, Noguchi K, Shimamoto T, Kato T.

Cancer Sci. 2019 Jan 7. doi: 10.1111/cas.13932. [Epub ahead of print]

3.

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Yamaguchi M, Shimamatsu S, Edagawa M, Hirai F, Toyozawa R, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Today. 2019 Jan 4. doi: 10.1007/s00595-018-1751-7. [Epub ahead of print]

PMID:
30610361
4.

ALK testing methods: Is there a winner or loser?

Kozuma Y, Toyokawa G, Seto T.

Expert Rev Anticancer Ther. 2018 Dec 21. doi: 10.1080/14737140.2019.1562343. [Epub ahead of print]

PMID:
30576255
5.

Establishment of a Healthcare System for Patients With Adult Congenital Heart Disease in Collaboration With Children's Hospital - The Nagano Model.

Motoki H, Yasukochi S, Takigiku K, Takei K, Okamura T, Kimura K, Minamisawa M, Okada A, Saigusa T, Ebisawa S, Seto T, Shoda M, Okada K, Kuwahara K.

Circ J. 2018 Dec 20. doi: 10.1253/circj.CJ-18-0705. [Epub ahead of print]

6.

Case of hand, foot and mouth disease with vesicular Koebner phenomenon on the ankles caused by Coxsackievirus A6 in an adult.

Shiratori M, Fukai K, Hikita N, Seto T, Tsuruta D.

J Dermatol. 2018 Dec 10. doi: 10.1111/1346-8138.14723. [Epub ahead of print] No abstract available.

PMID:
30536870
7.

Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer.

Seneviratne MG, Bozkurt S, Patel MI, Seto T, Brooks JD, Blayney DW, Kurian AW, Hernandez-Boussard T.

Cancer. 2018 Dec 4. doi: 10.1002/cncr.31895. [Epub ahead of print]

PMID:
30512191
8.

Gender Differences in the Rate of 30-Day Readmissions after Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Lam L, Ahn HJ, Okajima K, Schoenman K, Seto TB, Shohet RV, Miyamura J, Sentell TL, Nakagawa K.

Womens Health Issues. 2019 Jan - Feb;29(1):17-22. doi: 10.1016/j.whi.2018.09.002. Epub 2018 Oct 25.

PMID:
30482594
9.

First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer.

Kishi K, Sakai H, Seto T, Kozuki T, Nishio M, Imamura F, Nokihara H, Satouchi M, Nakagawa S, Tahata T, Nakagawa K.

Cancer Treat Res Commun. 2019;18:100113. doi: 10.1016/j.ctarc.2018.10.004. Epub 2018 Oct 31.

PMID:
30472556
10.

Thrombus "Squeezing" Through Patent Foramen Ovale After Traumatic Brain Injury.

Nakagawa K, Seto TB.

Neurocrit Care. 2018 Nov 16. doi: 10.1007/s12028-018-0646-1. [Epub ahead of print] No abstract available.

PMID:
30446933
11.

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.

Solomon BJ, Besse B, Bauer TM, Felip E, Soo RA, Camidge DR, Chiari R, Bearz A, Lin CC, Gadgeel SM, Riely GJ, Tan EH, Seto T, James LP, Clancy JS, Abbattista A, Martini JF, Chen J, Peltz G, Thurm H, Ou SI, Shaw AT.

Lancet Oncol. 2018 Dec;19(12):1654-1667. doi: 10.1016/S1470-2045(18)30649-1. Epub 2018 Nov 6. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30413378
12.

Atezolizumab in non-squamous non-small cell lung cancer.

Akamine T, Toyokawa G, Tagawa T, Seto T.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3155-S3159. doi: 10.21037/jtd.2018.07.92. No abstract available.

13.

A novel missense mutation of the STS gene in two siblings with X-linked ichthyosis, complicated by short stature, bone density reduction, epilepsy, and cryptorchidism.

Ohyama A, Nakano H, Imanishi Y, Seto T, Tsuruta D, Fukai K.

Clin Exp Dermatol. 2019 Jan;44(1):78-79. doi: 10.1111/ced.13741. Epub 2018 Sep 16. No abstract available.

PMID:
30221377
14.

The Influence of Culture on Teamwork and Communication in a Simulation-Based Resuscitation Training at a Community Hospital in Honduras.

Perry MF, Seto TL, Vasquez JC, Josyula S, Rule ARL, Rule DW, Kamath-Rayne BD.

Simul Healthc. 2018 Oct;13(5):363-370. doi: 10.1097/SIH.0000000000000323.

PMID:
30216273
15.

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.

Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, Nakagawa K, Nishimura Y, Yamamoto N, Nakanishi Y.

Br J Cancer. 2018 Sep;119(6):675-682. doi: 10.1038/s41416-018-0243-2. Epub 2018 Sep 12.

PMID:
30206369
16.

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date.

Akamine T, Toyokawa G, Tagawa T, Seto T.

Onco Targets Ther. 2018 Aug 22;11:5093-5101. doi: 10.2147/OTT.S165511. eCollection 2018. Review.

17.

Association between local-level resources for home care and home deaths: A nationwide spatial analysis in Japan.

Morioka N, Tomio J, Seto T, Yumoto Y, Ogata Y, Kobayashi Y.

PLoS One. 2018 Aug 24;13(8):e0201649. doi: 10.1371/journal.pone.0201649. eCollection 2018.

18.

Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.

Hamanaka K, Koyama T, Matsuoka S, Takeda T, Miura K, Yamada K, Hyogotani A, Seto T, Okada K, Ito KI.

Gen Thorac Cardiovasc Surg. 2018 Dec;66(12):731-735. doi: 10.1007/s11748-018-0996-9. Epub 2018 Aug 21.

PMID:
30132223
19.

Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer.

Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T.

EGEMS (Wash DC). 2018 Jun 1;6(1):13. doi: 10.5334/egems.234.

20.

Impact of Frailty on Outcomes in Acute Type A Aortic Dissection.

Gomibuchi T, Seto T, Komatsu M, Tanaka H, Ichimura H, Yamamoto T, Ohashi N, Wada Y, Okada K.

Ann Thorac Surg. 2018 Nov;106(5):1349-1355. doi: 10.1016/j.athoracsur.2018.06.055. Epub 2018 Aug 4.

PMID:
30086279
21.

Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging.

Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3011-3019. doi: 10.1167/iovs.17-23699.

22.
23.

Optical Detection of Macular Pigment Formation in Premature Infants.

Sasano H, Obana A, Sharifzadeh M, Bernstein PS, Okazaki S, Gohto Y, Seto T, Gellermann W.

Transl Vis Sci Technol. 2018 Jul 9;7(4):3. doi: 10.1167/tvst.7.4.3. eCollection 2018 Jul.

24.

Optic coherence tomography appearances of retinal astrocytic hamartoma and systemic features in tuberous sclerosis of Japanese patients.

Kato A, Obana A, Gohto Y, Seto T, Sasano H.

Eur J Ophthalmol. 2018 Jul 1:1120672118787441. doi: 10.1177/1120672118787441. [Epub ahead of print]

PMID:
29991284
25.

Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.

Murakami H, Nokihara H, Hayashi H, Seto T, Park K, Azuma K, Tsai CM, Yang JC, Nishio M, Kim SW, Kiura K, Inoue A, Takeda K, Kang JH, Nakagawa T, Takeda K, Akazawa R, Kaneko Y, Shimazaki M, Morita S, Fukuoka M, Nakagawa K.

Cancer Sci. 2018 Sep;109(9):2852-2862. doi: 10.1111/cas.13724. Epub 2018 Aug 9.

26.

Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.

Hida T, Seto T, Horinouchi H, Maemondo M, Takeda M, Hotta K, Hirai F, Kim YH, Matsumoto S, Ito M, Ayukawa K, Tokushige K, Yonemura M, Mitsudomi T, Nishio M.

Cancer Sci. 2018 Sep;109(9):2863-2872. doi: 10.1111/cas.13721. Epub 2018 Jul 25.

27.

A New Mode of Energy Transfer between Mn2+ and Eu2+ in Nitride-Based Phosphor SrAlSi4 N7 with Tunable Light and Excellent Thermal Stability.

Ding J, Seto T, Wang Y, Cao Y, Li H, Wang Y.

Chem Asian J. 2018 Sep 17;13(18):2649-2663. doi: 10.1002/asia.201800937. Epub 2018 Aug 20.

PMID:
29923354
28.

Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management.

Desai K, Carroll I, Asch SM, Seto T, McDonald KM, Curtin C, Hernandez-Boussard T.

J Surg Res. 2018 Aug;228:160-169. doi: 10.1016/j.jss.2018.03.029. Epub 2018 Apr 11.

PMID:
29907207
29.

Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).

Atagi S, Mizusawa J, Ishikura S, Takahashi T, Okamoto H, Tanaka H, Goto K, Nakagawa K, Harada M, Takeda Y, Nogami N, Fujita Y, Kasai T, Kishi K, Sawa T, Takeda K, Tomii K, Satouchi M, Seto T, Ohe Y.

Clin Lung Cancer. 2018 Sep;19(5):e619-e627. doi: 10.1016/j.cllc.2018.04.018. Epub 2018 May 5.

PMID:
29887243
30.

A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Kogure Y, Saka H, Takiguchi Y, Atagi S, Kurata T, Ebi N, Inoue A, Kubota K, Takenoyama M, Seto T, Kada A, Yamanaka T, Ando M, Yamamoto N, Gemma A, Ichinose Y.

Clin Lung Cancer. 2018 Sep;19(5):e711-e715. doi: 10.1016/j.cllc.2018.05.005. Epub 2018 May 19.

PMID:
29861395
31.

Mining Electronic Health Records to Extract Patient-Centered Outcomes Following Prostate Cancer Treatment.

Hernandez-Boussard T, Kourdis PD, Seto T, Ferrari M, Blayney DW, Rubin D, Brooks JD.

AMIA Annu Symp Proc. 2018 Apr 16;2017:876-882. eCollection 2017.

32.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

33.

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study.

Fujiwara Y, Takeda M, Yamamoto N, Nakagawa K, Nosaki K, Toyozawa R, Abe C, Shiga R, Nakamaru K, Seto T.

Oncotarget. 2018 May 4;9(34):23729-23737. doi: 10.18632/oncotarget.25263. eCollection 2018 May 4.

34.

Optimal Hematoma Volume Cut Points to Predict Functional Outcome After Basal Ganglia and Thalamic Hemorrhages.

Nakagawa K, King SL, Seto TB.

Front Neurol. 2018 May 1;9:291. doi: 10.3389/fneur.2018.00291. eCollection 2018.

35.

Is prophylactic cranial irradiation (PCI) needed in patients with extensive-stage small cell lung cancer showing complete response to first-line chemotherapy?

Nosaki K, Seto T, Shimokawa M, Takahashi T, Yamamoto N.

Radiother Oncol. 2018 Jun;127(3):344-348. doi: 10.1016/j.radonc.2018.04.010. Epub 2018 May 7. Review.

PMID:
29747871
36.

Disparities in Functional Outcome After Intracerebral Hemorrhage Among Asians and Pacific Islanders.

Nakagawa K, King SL, Seto TB, Mau MKLM.

Front Neurol. 2018 Mar 27;9:186. doi: 10.3389/fneur.2018.00186. eCollection 2018.

37.

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K.

J Clin Oncol. 2018 May 10;36(14):1405-1411. doi: 10.1200/JCO.2017.75.5587. Epub 2018 Mar 29.

PMID:
29596029
38.

Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population.

Obana A, Gohto Y, Moriyama T, Seto T, Sasano H, Okazaki S.

Jpn J Ophthalmol. 2018 Jul;62(4):473-480. doi: 10.1007/s10384-018-0588-3. Epub 2018 Mar 28.

PMID:
29594609
39.

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW.

Clin Cancer Res. 2018 Jun 15;24(12):2851-2858. doi: 10.1158/1078-0432.CCR-17-1323. Epub 2018 Mar 26.

PMID:
29581131
40.

Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.

Hida T, Kaji R, Satouchi M, Ikeda N, Horiike A, Nokihara H, Seto T, Kawakami T, Nakagawa S, Kubo T.

Clin Lung Cancer. 2018 Jul;19(4):e405-e415. doi: 10.1016/j.cllc.2018.01.004. Epub 2018 Feb 1.

41.

Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809.

Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Yoshiya K, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Saito H, Tsuchida M, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K.

Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000438. [Epub ahead of print]

PMID:
29521649
42.

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.

Kometani T, Sugio K, Osoegawa A, Seto T, Ichinose Y.

Thorac Cancer. 2018 May;9(5):563-570. doi: 10.1111/1759-7714.12616. Epub 2018 Mar 8.

43.

Valve-sparing aortic root replacement after double-switch operation for corrected transposition of the great arteries in a patient with ulcerative colitis.

Gomibuchi T, Okada K, Seto T, Okita Y.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):e175-e176. doi: 10.1016/j.jtcvs.2018.01.071. Epub 2018 Feb 10. No abstract available.

PMID:
29510935
44.

The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Seto T, Tagawa T, Takenoyama M, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.

PMID:
29500763
45.

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Okamoto I, Morita S, Tashiro N, Imamura F, Inoue A, Seto T, Yamamoto N, Ohe Y, Nakagawa K, Fukuoka M.

Lung Cancer. 2018 Mar;117:14-19. doi: 10.1016/j.lungcan.2018.01.005. Epub 2018 Jan 9.

46.

Reliability of a two-wavelength autofluorescence technique by Heidelberg Spectralis to measure macular pigment optical density in Asian subjects.

Obana A, Gellermann W, Gohto Y, Seto T, Sasano H, Tanito M, Okazaki S.

Exp Eye Res. 2018 Mar;168:100-106. doi: 10.1016/j.exer.2017.12.015. Epub 2018 Jan 20.

PMID:
29357284
47.

Increased Expression of Y-Box-Binding Protein-1 in Hind-Limb Muscles During Regeneration from Ischemic Injury in Mice.

Fuke M, Narita M, Wada Y, Seto T, Okada K, Nakayama J, Izumi H, Ito KI.

Tohoku J Exp Med. 2018 Jan;244(1):53-62. doi: 10.1620/tjem.244.53.

48.

Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.

Kojima A, Fukushima Y, Ito Y, Ding WG, Ueda R, Seto T, Kitagawa H, Matsuura H.

J Cardiovasc Pharmacol. 2018 Jan;71(1):10-18. doi: 10.1097/FJC.0000000000000538.

PMID:
29283926
49.

Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i.

Taira D, Sentell T, Albright C, Lansidell D, Nakagawa K, Seto T, Stevens JM.

Hawaii J Med Public Health. 2017 Nov;76(11):314-317.

50.

Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups.

Taira DA, Seto BK, Davis JW, Seto TB, Landsittel D, Sumida WK.

J Pharm Health Serv Res. 2017 Dec;8(4):247-253. doi: 10.1111/jphs.12193. Epub 2017 Aug 7.

Supplemental Content

Support Center